Icon

IMITREX (nda020080)- (EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML))

SUMATRIPTAN SUCCINATE GLAXOSMITHKLINE
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
No No
2009-Feb-06 Expired
None None
None No
IMITREX injection is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for: • Acute treatment of migraine with or without aura in adults. • Acute treatment of cluster headache in adults.
8 0 6
Total Other Developers 1
Drugs with Suitability No
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) ** ** - - 4
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***
****** ***** ***** ************ (********), *.* *********** ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ******** ****** ******* ******* *** *********** ****-**, ****** **. ** & **, ************* ******* ***- *********, ******** ******, **********, ********* ******, ***** (***) ***
****** ******** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***
****** ****** ******** **** ****** *************** ***** ******* ******* *********** ******* ******-***********, ****** ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.